Join us for the upcoming CELS Valley Ready Seminar Series
While no business will be spared by the economic impact of Covid-19, there is an intense focus on access to healthcare products at all levels as we navigate through and beyond this pandemic. Ali Samiian, Director of Marketing, US Market Access at Abbott Diabetes Care will join us in conversation to reference the current payer and manufacturer perspectives. Ali Samiian will share current thoughts on how to shrewdly manage the realities of the unprecedented situation we are facing with Covid-19.
His comments will be followed by a Q&A to address participant's questions.
Date: Friday, May 1, 2020
Time: 11:00 am - 12:00 pm PDT (Pacific Time)
Join Info: Dial-in & Web Access Information Provided with Registration
Ali Samiian, Director of Marketing, US Market Access, Abbott Diabetes Care
A lawyer by training, Ali has worked in government in the healthcare sector providing policy advice to the Minister of Health in Ontario, Canada on Pharmaceuticals, Diagnostic devices, and physician negotiations. He has over 15 years of experience working in the pharmaceutical and medical device sector in several roles of increasing responsibility, including market access, sales, and strategic planning in global, regional and country affiliate organizations. He has launched products in Canada, Europe, US and several Asia Pacific markets.
Ali holds a JD from Osgoode Hall Law School, an MBA from the Schulich School of Business in Canada, and a MSc in Health Economics, Policy and Management from the London School of Economics.
He served for 5 years as the global head of Market Access, Health Economics and Pricing at Abbott Diabetes Care, managing a team to ensure global reimbursement of a new glucose sensing category. He is currently working as the director of Marketing, US Market Access. He is a proud husband and father of 2.